Cargando…
Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells
The overexpressing ABCB1 transporter is one of the key factors leading to multidrug resistance (MDR). Thus, many ABCB1 inhibitors have been found to be able to overcome ABCB1-mediated MDR. However, some inhibitors also work as a substrate of ABCB1, which indicates that in order to achieve an effecti...
Autores principales: | Wang, Jingqiu, Yang, Dong-Hua, Yang, Yuqi, Wang, Jing-Quan, Cai, Chao-Yun, Lei, Zi-Ning, Teng, Qiu-Xu, Wu, Zhuo-Xun, Zhao, Linguo, Chen, Zhe-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073023/ https://www.ncbi.nlm.nih.gov/pubmed/32092870 http://dx.doi.org/10.3390/ijms21041387 |
Ejemplares similares
-
Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice
por: Weber, Helga, et al.
Publicado: (2015) -
WYE-354 restores Adriamycin sensitivity in multidrug-resistant acute myeloid leukemia cell lines
por: Ibrahim, Sara M., et al.
Publicado: (2019) -
Reversal Effect of ALK Inhibitor NVP-TAE684 on ABCG2-Overexpressing Cancer Cells
por: Wang, Jingqiu, et al.
Publicado: (2020) -
Overexpression of ABCG2 Confers Resistance to MLN7243, a Ubiquitin-Activating Enzyme (UAE) Inhibitor
por: Wu, Zhuo-Xun, et al.
Publicado: (2021) -
Overexpression of ABCC1 Confers Drug Resistance to Betulin
por: Chen, Xuan-Yu, et al.
Publicado: (2021)